These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34108990)

  • 1. Discovery and Verification of an Immune-Related Gene Pairs Signature for Predicting Prognosis in Head and Neck Squamous Cell Carcinoma.
    He J; Fang X; Han M
    Front Genet; 2021; 12():654657. PubMed ID: 34108990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
    Zhang F; Liu Y; Yang Y; Yang K
    BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma.
    Dong L; Sun Q; Song F; Song X; Lu C; Li Y; Song X
    Heliyon; 2023 Mar; 9(3):e14003. PubMed ID: 36938461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Verification of an Immune-Related Gene Pairs Prognostic Signature in Hepatocellular Carcinoma.
    Feng X; Mu S; Ma Y; Wang W
    Front Mol Biosci; 2021; 8():715728. PubMed ID: 34660693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A signature of immune-related gene pairs (IRGPs) for risk stratification and prognosis of oral cancer patients.
    Yu Y; Tian J; Hou Y; Zhang X; Li L; Cong P; Ji L; Wang X
    World J Surg Oncol; 2022 Jul; 20(1):227. PubMed ID: 35804390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Validation of an Individualized Immune Prognostic Signature for Recurrent Prostate Cancer.
    Jin Y; Wang L; Lou H; Song C; He X; Ding M
    Comb Chem High Throughput Screen; 2021; 24(1):98-108. PubMed ID: 32593277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
    Song D; Tian J; Han X; Li X
    Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of a Five-immune Gene Pair Signature in Endometrial Carcinoma.
    Li N; Yu K; Lin Z; Zeng D
    Comb Chem High Throughput Screen; 2021; 24(2):233-245. PubMed ID: 32729416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A signature of 18 immune-related gene pairs to predict the prognosis of pancreatic cancer patients.
    Bu F; Nie H; Zhu X; Wu T; Lin K; Zhao J; Huang J
    Immun Inflamm Dis; 2020 Dec; 8(4):713-726. PubMed ID: 33128857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
    Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
    PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A signature of 17 immune-related gene pairs predicts prognosis and immune status in HNSCC patients.
    Jiang P; Li Y; Xu Z; He S
    Transl Oncol; 2021 Jan; 14(1):100924. PubMed ID: 33221687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
    Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
    BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Immune-Related Gene Pairs Signature for Predicting Survival in Glioblastoma.
    Wang S; Xu X
    Front Oncol; 2021; 11():564960. PubMed ID: 33859933
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of a metabolic reprogramming-related signature associated with prognosis and immune microenvironment of head and neck squamous cell carcinoma by in silico analysis.
    Qiang W; Dai Y; Xing X; Sun X
    Cancer Med; 2022 Aug; 11(16):3168-3181. PubMed ID: 35301800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of a Prognostic Signature Based on the Lysine Crotonylation Regulators in Head and Neck Squamous Cell Carcinoma.
    Jiang L; Yin X; Zhang H; Zhang X; Cao Z; Zhou M; Xu W
    Biomed Res Int; 2023; 2023():4444869. PubMed ID: 36814797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel prognostic matrisome-related gene signature of head and neck squamous cell carcinoma.
    Huang C; Liang Y; Dong Y; Huang L; Li A; Du R; Huang H
    Front Cell Dev Biol; 2022; 10():884590. PubMed ID: 36081907
    [No Abstract]   [Full Text] [Related]  

  • 17. A novel immune-related gene pair prognostic signature for predicting overall survival in bladder cancer.
    Fu Y; Sun S; Bi J; Kong C; Yin L
    BMC Cancer; 2021 Jul; 21(1):810. PubMed ID: 34266411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a novel hypoxia-related signature for prognostic and immunogenic evaluation in head and neck squamous cell carcinoma.
    Li SR; Man QW; Liu B
    Front Oncol; 2022; 12():943945. PubMed ID: 36452497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a hypoxia-related gene pair signature to predict overall survival in head and neck squamous cell carcinoma.
    Ding Z; Li H; Yu D
    Eur Arch Otorhinolaryngol; 2021 Oct; 278(10):3973-3983. PubMed ID: 33449166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of Radiosensitivity Gene Signature and PD-L1 Status Predicts Clinical Outcome of Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma: A Study Based on The Cancer Genome Atlas Dataset.
    Dai D; Guo Y; Shui Y; Li J; Jiang B; Wei Q
    Front Mol Biosci; 2021; 8():775562. PubMed ID: 34970597
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.